This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xinarianos, G. Articles by Field, J. K. Search for Related Content PubMed PubMed Citation Articles by Xinarianos, G. Articles by Field, J. K.

hMLH1 and hMSH2 Expression Correlates with Allelic Imbalance on Chromosome 3p in Non-Small Cell Lung Carcinomas¹

Molecular Oncology Unit, Roy Castle International Centre for Lung Cancer Research, Liverpool L3 9TA, Merseyside [G. X., T. L., W. P., P. M., J. C., P. F., J. K. F.]; Molecular Genetics and Oncology Group, Department of Clinical Dental Sciences, The University of Liverpool, Liverpool L69 3BX [G. X., T. L., P. M., J. C., P. F., J. K. F.]; and Department of Pathology, Medical School, The University of Liverpool, Liverpool L69 3GA [W. P., J. R. G.], United Kingdom

DNA mismatch repair genes have been implicated in the pathogenesis and predisposition of certain malignancies through a mutator phenotype. In this study, we investigated, in 150 non-small cell lung carcinomas, the expression levels of hMLH1 and hMSH2 proteins in relation to loss of heterozygosity on chromosomes 3p and 2p, the mutational status of these genes’ promoters and the hot spot exons. We have demonstrated that 88 of 150 (58.6%) tumor specimens had reduced expression levels of the hMLH1 protein, whereas 85 of 147 (57.8%) specimens had reduced expression levels of the hMSH2 protein. Reduced expression levels of both proteins were observed in 51 of 150 (34%) specimens. In adenocarcinomas, the reduction of hMSH2 expression was more frequently observed than that of hMLH1 (P < 0.003), whereas in squamous cell carcinoma of the lung hMLH1 expression was more frequently reduced than hMSH2 (P < 0.006). Reduced expression of hMLH1 correlated with allelic imbalance on loci D3S1289 (P < 0.0002) and D2S391 (P < 0.05). It is of note that an inverse correlation was found between hMSH2 reduced expression and loss of heterozygosity at locus D3S1300 (P = 0.016). In addition, hMLH1 reduced expression was more frequently associated with heavy smokers, assessed by daily tobacco uptake (P = 0.018) and total smoking exposure (pack-years; P < 0.05). In addition, a correlation between hMLH1 reduced expression and nodal metastasis in squamous cell carcinoma of the lung was observed (P = 0.015). No mutations were identified in the promoters or exons examined in these two genes. These findings indicate that hMLH1 and hMSH2 gene inactivation is a common event in the development of non-small cell lung carcinoma and allelic loss seems to be a major genetic event involved in hMLH1 silencing. In addition, we propose that a putative negative regulator of hMSH2 gene may be located at the locus 3p14.

This article has been cited by other articles:

				H.-C. WANG, C.-F. CHIU, R.-Y. TSAI, Y.-S. KUO, H.-S. CHEN, R.-F. WANG, C.-W. TSAI, C.-H. CHANG, C.-C. LIN, and D.-T. BAU Association of Genetic Polymorphisms of EXO1 Gene with Risk of Breast Cancer in Taiwan Anticancer Res, October 1, 2009; 29(10): 3897 - 3901. [Abstract] [Full Text] [PDF]

				A Canney, K Sheahan, D Keegan, M Tolan, J Hyland, and A Green Synchronous lung tumours in a patient with metachronous colorectal carcinoma and a germline MSH2 mutation J. Clin. Pathol., May 1, 2009; 62(5): 471 - 473. [Abstract] [Full Text] [PDF]

				N.-Y. HSU, H.-C. WANG, C.-H. WANG, C.-F. CHIU, H.-C. TSENG, S.-Y. LIANG, C.-W. TSAI, C.-C. LIN, and D.-T. BAU Lung Cancer Susceptibility and Genetic Polymorphisms of Exo1 Gene in Taiwan Anticancer Res, February 1, 2009; 29(2): 725 - 730. [Abstract] [Full Text] [PDF]

				S. Landi, F. Gemignani, F. Canzian, V. Gaborieau, R. Barale, D. Landi, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, et al. DNA Repair and Cell Cycle Control Genes and the Risk of Young-Onset Lung Cancer. Cancer Res., November 15, 2006; 66(22): 11062 - 11069. [Abstract] [Full Text] [PDF]

				C. Y. Jung, J. E. Choi, J. M. Park, M. H. Chae, H.-G. Kang, K. M. Kim, S. J. Lee, W. K. Lee, S. Kam, S. I. Cha, et al. Polymorphisms in the hMSH2 Gene and the Risk of Primary Lung Cancer. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 762 - 768. [Abstract] [Full Text] [PDF]

				H.-S. Hsu, C.-K. Wen, Y.-A. Tang, R.-K. Lin, W.-Y. Li, W.-H. Hsu, and Y.-C. Wang Promoter Hypermethylation Is the Predominant Mechanism in hMLH1 and hMSH2 Deregulation and Is a Poor Prognostic Factor in Nonsmoking Lung Cancer Clin. Cancer Res., August 1, 2005; 11(15): 5410 - 5416. [Abstract] [Full Text] [PDF]

				F. Chiappini, M. Gross-Goupil, R. Saffroy, D. Azoulay, J.-F. Emile, L.-A. Veillhan, V. Delvart, S. Chevalier, H. Bismuth, B. Debuire, et al. Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers Carcinogenesis, April 1, 2004; 25(4): 541 - 547. [Abstract] [Full Text] [PDF]

				T. J. Koh, J. K. Field, A. Varro, T. Liloglou, P. Fielding, G. Cui, J. Houghton, G. J. Dockray, and T. C. Wang Glycine-Extended Gastrin Promotes the Growth of Lung Cancer Cancer Res., January 1, 2004; 64(1): 196 - 201. [Abstract] [Full Text] [PDF]

				P. Peltomaki Role of DNA Mismatch Repair Defects in the Pathogenesis of Human Cancer J. Clin. Oncol., March 15, 2003; 21(6): 1174 - 1179. [Abstract] [Full Text] [PDF]